Literature DB >> 3940642

Differential expression of intermediate filament proteins in metastatic and nonmetastatic variants of the BSp73 tumor.

A Ben-Ze'ev, M Zöller, A Raz.   

Abstract

The pattern of intermediate filament protein expression was studied in tumor cell variants of the BSp73 spontaneous rat adenocarcinoma of the pancreas exhibiting distinct morphology and metastatic phenotype. The non-metastasizing AS cells which adhere and spread on a solid substrate express only the vimentin type mesenchymal intermediate filament protein. The ASML metastatic cell variant which adheres but does not spread on the substrate expresses a complex pattern of cytokeratins characteristic of the adenocarcinoma of the pancreas and a low level of vimentin. The differences in the expression of the intermediate filament proteins between the variants were also reflected at the level of the corresponding mRNAs as revealed by RNA blot analysis with complementary DNA clones specific to vimentin and the acidic as well as the basic cytokeratin subfamily. When the two cell variants were cultured for 72 h in suspension culture on nonadhesive substrata the AS cells responded with a marked reduction in their vimentin synthesis. The ASML variant cells which are characterized by a round configuration in both monolayer and suspension culture continue to synthesize the same intermediate filament proteins under both culture conditions. The relationships among environmental conditions that affect cell shape and contacts, the shifts in the expression of intermediate filaments, and the metastatic property of tumor cells are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3940642

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Cytokeratin 19 fragment in serum and tissues of patients with pancreatic diseases.

Authors:  G Ohshio; T Imamura; N Okada; K Yamaki; H Suwa; M Imamura; H Sakahara
Journal:  Int J Pancreatol       Date:  1997-06

2.  Regulation of keratin and integrin gene expression in cancer and drug resistance.

Authors:  N Daly; P Meleady; D Walsh; M Clynes
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

Review 3.  Role of intermediate filaments in migration, invasion and metastasis.

Authors:  M J Hendrix; E A Seftor; Y W Chu; K T Trevor; R E Seftor
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

Review 4.  Intermediate filaments.

Authors:  M J Hendrix
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

5.  Altered intermediate filament expression in human neuroblastoma cells transformed by a growth-promoting agent derived from schizophrenic CSF.

Authors:  S Shirabe; W H Fang; J P Schwartz
Journal:  Cell Mol Neurobiol       Date:  1997-02       Impact factor: 5.046

Review 6.  Cell-contact and -architecture of malignant cells and their relationship to metastasis.

Authors:  A Raz; A Ben-Ze'ev
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility.

Authors:  Y W Chu; E A Seftor; L H Romer; M J Hendrix
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

8.  Expression of complete keratin filaments in mouse L cells augments cell migration and invasion.

Authors:  Y W Chu; R B Runyan; R G Oshima; M J Hendrix
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  Changes in adhesive properties of tumor cells do not necessarily influence metastasizing capacity.

Authors:  M Zöller; S Matzku
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

10.  Establishment and characterization of a cultured cell line derived from nitrosamine-induced pancreatic ductal adenocarcinoma in Syrian golden hamsters.

Authors:  S Saito; N Nishimura; Y Kubota; K Yamazaki; T Shibuya; H Sasaki
Journal:  Gastroenterol Jpn       Date:  1988-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.